Immunotherapy of primary liver cancer. A control study of 51 patients.

dc.contributor.authorPlengvanit, Uen_US
dc.contributor.authorChearanai, Oen_US
dc.contributor.authorAsavanich, Cen_US
dc.contributor.authorRungpitarangsi, Ben_US
dc.contributor.authorYongchaiyud, Uen_US
dc.contributor.authorViranuvatti, Ven_US
dc.date.accessioned2009-05-27T18:42:07Z
dc.date.available2009-05-27T18:42:07Z
dc.date.issued1986-02-01en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.identifier.citationPlengvanit U, Chearanai O, Asavanich C, Rungpitarangsi B, Yongchaiyud U, Viranuvatti V. Immunotherapy of primary liver cancer. A control study of 51 patients. Journal of the Medical Association of Thailand. 1986 Feb; 69(2): 59-64en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/39675
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshAdenoma, Bile Duct --drug therapyen_US
dc.subject.meshAdulten_US
dc.subject.meshBile Duct Neoplasms --drug therapyen_US
dc.subject.meshCarcinoma, Hepatocellular --drug therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLevamisole --therapeutic useen_US
dc.subject.meshLiver Neoplasms --drug therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.titleImmunotherapy of primary liver cancer. A control study of 51 patients.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: